The very high level of CXCR4 expression in those cancers, compared to healthy tissues, places this receptor as an interesting marker for diagnosis but also, as a potential tool for precise targeting and selective delivery of antitumoral drugs [50–52]. Here, CXCR4 is linked to cancer.